Researchers at the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures have, for the first time, identified a model cell line for a rare form of acute myeloid leukemia (AML).
Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively with tumors and deliver mRNA therapy with minimal off-target effects. That ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results